• Citer

Erratum to: Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial (Breast Cancer Research and Treatment, (2017), 165, 2, (329-341), 10.1007/s10549-017-4304-7)

par Cortes, Javier;Rugo, Hope H.S.;Awada, Ahmad ;Twelves, Chris;Perez, Edith A;Im, Seock–Ah –A;Gómez-Pardo, Patricia;Schwartzberg, Lee L.S.;Diéras, Veronique;Yardley, Denise;Potter, David D.A.;Mailliez, Audrey;Moreno-Aspitia, Alvaro;Ahn, Jin Seok;Zhao, Carol;Hoch, Ute;Tagliaferri, Mary;Hannah, Alison L;O’Shaughnessy, Joyce
Référence Breast cancer research and treatment, 165, 2, page (329-341)
Publication Publié, 2017-09

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Erratum to: Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial (Breast Cancer Research and Treatment, (2017), 165, 2, (329-341), 10.1007/s10549-017-4304-7)
Auteur:	Cortes, Javier; Rugo, Hope H.S.; Awada, Ahmad; Twelves, Chris; Perez, Edith A; Im, Seock–Ah –A; Gómez-Pardo, Patricia; Schwartzberg, Lee L.S.; Diéras, Veronique; Yardley, Denise; Potter, David D.A.; Mailliez, Audrey; Moreno-Aspitia, Alvaro; Ahn, Jin Seok; Zhao, Carol; Hoch, Ute; Tagliaferri, Mary; Hannah, Alison L; O’Shaughnessy, Joyce
Informations sur la publication:	Breast cancer research and treatment, 165, 2, page (329-341)
Statut de publication:	Publié, 2017-09
Sujet CREF:	Généralités
Mots-clés:	Brain metastases
	Etirinotecan pegol
	NKTR-102
	Chemotherapy
	Metastatic breast cancer
Note générale:	SCOPUS: er.j
Langue:	Anglais
Identificateurs:	urn:issn:0167-6806
	info:doi/10.1007/s10549-017-4482-3
	info:scp/85029009056